-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Shanghai Kaisai Biotechnology Co.
, Ltd.
(hereinafter referred to as "Kaisai Bio") is a high-tech enterprise engaged in the research and development, production and sales of new bio-based materials based on synthetic biology and other disciplines, using biological manufacturing technology
.
Products currently in commercial production mainly focus polyamidesThe industrial chain is bio-based polyamide and raw materials that can be used for bio-based polyamide production, including bio-based long-chain dibasic acid series products such as DC12 (lauric acid) and DC13 (brazilian acid), and bio-based pentamethylene diamine
.
Pyropolyamide _Polyamide
01.
Listing and fundraising projects
Listing and fundraising projects
On August 12, 2020, Kasai Bio (stock code: 688065) officially landed on the Science and Technology Innovation Board of the Shanghai Stock Exchange; and raised funds to invest in the following projects: Kasai (Jinxiang) Biomaterials Co.
, Ltd.
40,000 tons/year Biological sebacic acid project, Kasai (Wusu) Biotechnology Co.
, Ltd.
with an annual output of 30,000 tons of long-chain dibasic acid and 20,000 tons of long-chain polyamide projects to supplement working capital
.
1.
40,000 tons/year biological sebacic acid project of Kasai (Jinxiang) Biomaterials Co.
, Ltd.
40,000 tons/year biological sebacic acid project of Kasai (Jinxiang) Biomaterials Co.
, Ltd.
This project is implemented by Jinxiang Kaisai.
It is planned to build a new 40,000-ton biological sebacic acid production capacity and develop the biological sebacic acid market
.
2.
Bio-based Polyamide Engineering Technology Research Center
Bio-based Polyamide Engineering Technology Research Center
This project is implemented by Jinxiang Kaisai and plans to become one of the main R&D bases of the company's bio-based polyamide engineering technology
.
3.
Kasai (Wusu) Biotechnology Co.
, Ltd.
project with an annual output of 30,000 tons of long-chain dibasic acid and 20,000 tons of long-chain polyamide
Kasai (Wusu) Biotechnology Co.
, Ltd.
project with an annual output of 30,000 tons of long-chain dibasic acid and 20,000 tons of long-chain polyamide
The project is implemented by Wusu Technology and will achieve an annual production capacity of 30,000 tons of long-chain dibasic acids and 20,000 tons of bio-based long-chain polyamide products
.
4.
Supplementary working capital
Supplementary working capital
The company plans to use the raised funds of 2 billion yuan to supplement working capital to optimize the financial structure, reduce liquidity risks, and meet the company's capital needs for subsequent production and operation development
.
02.
Financial data
Financial data
From 2017 to 2019, the main financial data and financial indicators of Kasai Bio are as follows:
From 2017 to 2019, the main business income of Kasai Bio is classified by product as follows:
From 2017 to 2019, the main business income of Kasai Bio at home and abroad is shown in the following table:
03.
R&D investment
R&D investment
In 2017, 2018 and 2019, the company's research and development expenses were 64.
5602 million yuan, 86.
3938 million yuan and 90.
1595 million yuan respectively, accounting for 4.
74%, 4.
92% and 4.
71% of operating income respectively
.
The company has established a multidisciplinary professional R&D team with rich experience in molecular biology, chemistry, polymerization, and material application
.
As of December 31, 2019, the number of core technical personnel and R&D personnel of the company is as follows:
04.
Production capacity statistics
Production capacity statistics
According to public information, Kasai Bio has a production capacity of 75,000 tons/year of biological long-chain dibasic acids, currently 100,000 tons/year of bio-based polyamide, 50,000 tons/year of bio-based pentamethylene diamine and 40,000 tons/year of bio-based pentanediamine.
Bio-based sebacic acid/year is in the process of industrialization, and 20,000 tons/year of bio-based long-chain polyamide is in the laboratory research and development stage
.
In addition, the company will realize the industrialization of 900,000 tons/year bio-based polyamide and 500,000 tons/year bio-based pentamethylene diamine in Shanxi base in the future
.
05.
Main customers
Main customers
